Telomere Length and Oxidative Damage in Children and Adolescents with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis

Lin Ma, Cui Liu, Ran Song, Yuetong Qian, Feng ZhangJournal of Integrative Neuroscience 2025 · DOI

TL;DR

This comprehensive meta-analysis of 39 studies confirms that children and adolescents with Autism Spectrum Disorder (ASD) exhibit significantly shorter telomeres and higher levels of oxidative damage to DNA, lipids, and proteins. These findings suggest that ASD may be associated with accelerated biological aging and identify specific molecular markers that could eventually aid in early diagnosis.

What Problem Does This Paper Address?

Autism Spectrum Disorder (ASD) is primarily diagnosed through behavioral observations, but researchers have long sought objective biological markers. Clinical data shows that individuals with ASD face an increased risk of premature mortality from natural causes, leading to the hypothesis that ASD might involve "accelerated biological aging."

Two key players in biological aging are telomeres (the protective caps on chromosomes that shorten as cells divide) and oxidative stress (an imbalance of free radicals that damages cellular components). While many individual studies have looked at telomere length (TL) and oxidative markers in ASD, the results have been frustratingly inconsistent. Some studies showed significant shortening, while others found no difference. This paper performs a systematic meta-analysis to resolve these contradictions and determine if a consistent molecular signature exists across the ASD population.

Methods

The researchers conducted a systematic review following PRISMA guidelines, searching PubMed and Embase for studies published through April 2024. They focused specifically on children and adolescents (under 22 years old) to capture early-life biological changes.

To synthesize the data, they used:

  • Standardized Mean Difference (SMD): A statistical tool to compare results across studies that might use different measurement units.
  • Random-effects models: Used to account for high heterogeneity (variation) between different study populations.
  • Publication Bias Correction: They employed the "Egger’s test" and the "trim-and-fill" method to ensure that the results weren't skewed by the tendency of journals to only publish "positive" findings.
  • Sensitivity Analysis: A "leave-one-out" approach to ensure no single study was disproportionately driving the overall results.

Datasets

The meta-analysis synthesized data from 39 eligible studies involving thousands of participants across various countries (USA, China, Egypt, Japan, etc.).

  • Primary Variables: Telomere length (measured via PCR) and various oxidative stress biomarkers.
  • Control Groups: Typically developing (TD) children or unaffected siblings.
  • Sample Sources: Included blood, urine, saliva, and in some cases, brain tissue.

Key Insights and Ideas

  • The Male Factor: One of the most striking findings was that telomere shortening was highly significant in males with ASD, but not statistically significant in females. Given that ASD is diagnosed roughly three times more often in males, this suggests a sex-specific biological vulnerability.
  • A Multi-Front Attack: Oxidative stress in ASD isn't localized to one area. The study found a "triple threat" of damage:
  • DNA: Higher levels of 8-OHdG.
  • Lipids: Increased HEL (hexanolyl-lysine).
  • Proteins: Elevated 3-NT and dityrosine (DT).
  • The Antioxidant Gap: It’s not just that there are more "bad actors" (oxidants); the body’s "defense force" (Total Antioxidant Capacity or TAC) is significantly lower in children with ASD.
  • Biological Aging vs. Chronological Age: The shortened telomeres suggest that at a cellular level, children with ASD may be "older" than their chronological age, which correlates with the observed clinical risks of premature natural death.

Key Results

The meta-analysis provided strong quantitative evidence for several biomarkers (expressed as SMD, where a negative value means lower in ASD and a positive value means higher):

  • Telomere Length (TL): Significantly shorter in ASD (SMD = –0.48, p < 0.001).
  • Total Antioxidant Capacity (TAC): Significantly lower (SMD = –1.15, p = 0.008).
  • DNA Damage (8-OHdG): Significantly higher (SMD = 0.63, p = 0.039).
  • Protein Damage (3-NT & DT): Both significantly higher (SMD = 0.86 and 0.66, respectively).
  • Lipid Damage (HEL): Significantly higher (SMD = 0.37, p = 0.003).

Interestingly, some markers like 8-isoprostane and the Oxidative Stress Index (OSI) lost their statistical significance after the researchers corrected for publication bias, highlighting the importance of rigorous meta-analytical techniques.

Limitations and Future Work

The authors acknowledge several hurdles before these findings can be used in a clinic:

  • Sample Size: While the overall meta-analysis is robust, some specific biomarkers (like NFK) were only measured in a few studies.
  • Diagnostic Thresholds: The study identifies differences, but it doesn't yet establish "cut-off" values that a doctor could use to diagnose an individual child.
  • Longitudinal Data: Most included studies were cross-sectional (a snapshot in time). We don't yet know if telomeres in ASD shorten faster over time or if they start shorter from birth.
  • The "Why": While the link between oxidative stress and telomere erosion is clear, the root cause of the oxidative stress in ASD remains an open question for future research.

The researchers suggest that future work should focus on DNA repair gene expression and larger, more diverse longitudinal cohorts to see if antioxidant interventions could potentially slow this biological aging process.

Summary updated

Abstract

TL, 8-OHdG, TAC, HEL, 3-NT, and DT represent potential biomarkers for prediction of ASD in children and adolescents.
BibTeX
@article{ma2025telomere,
  author = {Lin Ma and Cui Liu and Ran Song and Yuetong Qian and Feng Zhang},
  title = {{Telomere Length and Oxidative Damage in Children and Adolescents with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis}},
  journal = {Journal of Integrative Neuroscience},
  year = {2025},
  doi = {10.31083/jin24948},
}
Figure